Tagged With psilocybin

The active ingredient that makes magic mushrooms so magic — the psychedelic drug¬†psilocybin — is one step closer to becoming a legal treatment for difficult cases of depression. This week, the company Compass Pathways announced that it had received the Food and Drug Administration's Breakthrough Therapy designation for its psilocybin-based treatment. The designation will fast track the FDA's review of the treatment for possible approval.